Cryoport, Inc.

CYRX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.5B · 738 employees
337
SEC Filings
$15.69
Close 2026-05-29
738
Employees

Business Summary

Cryoport, Inc. is a life sciences company providing temperature-controlled supply chain solutions, primarily serving the cell and gene therapy markets. The company offers cold chain logistics services and related technologies to support the transport of biologic materials. Cryoport previously operated CRYOPDP, a logistics subsidiary, which it divested and formed a strategic partnership with DHL as part of its ongoing business restructuring.

Latest Stock Quote

CYRX 2026-05-29 $15.69 O:$15.22 H:$15.845 L:$15.02 Vol:1.6M VWAP:$15.605
origin leaf: f2e458fcc767e6d180b3e2739f61e0a3f57b59eb7b09ca0cd1be04cc633add02

Next Earnings

Q2 FY2026 — expected 2026-08-07

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001104659-26-024180EDGAR66K words
2025-03-072024-12-310001558370-25-002509EDGAR
2024-03-132023-12-310001558370-24-003128EDGAR
2023-02-282022-12-310001410578-23-000188EDGAR
2022-02-282021-12-310001410578-22-000232EDGAR
2021-03-012020-12-310001104659-21-030112EDGAR
2020-03-102019-12-310001104659-20-031407EDGAR
2019-03-132018-12-310001144204-19-013692EDGAR
2018-03-082017-12-310001144204-18-013595EDGAR
2016-06-282016-03-310001144204-16-110227EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001104659-25-107640EDGAR31K words
2025-08-122025-06-300001558370-25-011127EDGAR
2025-05-082025-03-310001558370-25-007012EDGAR
2024-11-072024-09-300001558370-24-014896EDGAR
2024-08-082024-06-300001558370-24-011562EDGAR
2024-05-082024-03-310001558370-24-007133EDGAR
2023-11-092023-09-300001558370-23-018511EDGAR
2023-08-092023-06-300001410578-23-001635EDGAR
2023-05-042023-03-310001410578-23-000882EDGAR
2022-11-042022-09-300001410578-22-002947EDGAR
2022-08-042022-06-300001410578-22-002045EDGAR
2022-05-052022-03-310001410578-22-001150EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-030001104659-26-022940EDGAR7K words
2025-11-040001104659-25-106421EDGAR
2025-08-060001104659-25-074314EDGAR
2025-06-130001558370-25-008613EDGAR
2025-06-100001104659-25-058019EDGAR
2025-05-070001104659-25-045557EDGAR
2025-03-310001104659-25-029642EDGAR
2025-03-040001104659-25-020404EDGAR
2024-11-070001104659-24-115344EDGAR
2024-08-060001104659-24-086344EDGAR

337 total filings indexed. 305 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

cell-and-gene-therapy life-sciences biologic-materials-logistics

Company Identity

CIK0001124524
TickerCYRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV
Websitehttps://www.cryoportinc.com
Listed1993-07-16

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 48cbde760cd7094410dae85183476218afeda983de639759f6eb21c902a48d19
parent: 25631ffdec49668f6b230d85e75c3e87c07bfedfd548f8f3a29f212c246b4610
content hash: f729daa0679d76f0645ab3c9e58c616f6683840d5a2ab9bbf8dfd28caadec55b
signed: 2026-06-03T12:00:48.877Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf